Covishield Maker AstraZeneca Withdraws Covid-19 Vaccine Globally, Cites 'Surplus Of Available Updated Vaccines'
According to AstraZeneca, the vaccination has been replaced by revised shots that address novel variations.
May 08, 2024, 09:59 AM IST
DNA: AstraZeneca's Covid vaccine may cause blood clotting
British company Astrazeneca, which manufactures Corona vaccine, has admitted that their vaccine can cause TTS i.e. Thrombosis Thrombocytopenia Syndrome in some cases.
May 01, 2024, 02:16 AM IST
AstraZeneca's Covishield Vaccine Can Lead To Rare Blood Clots As Side Effect: Know All About TTS
British pharma bigwig AstraZeneca has admitted that its COVID-19 vaccine can lead to a rare blood clotting condition known as Thrombosis with Thrombocytopenia Syndrome (TTS).
Apr 30, 2024, 15:53 PM IST
Man demands Rs 1,000 crore from Covid-19 vaccine makers for daughter's death; Bombay HC issues notice to SII, Bill Gates, others
The petitioner claimed that his daughter, a medical student, was compelled to take the Covid-19 vaccine at her college in Nashik in January as she was a health worker.
Sep 03, 2022, 09:44 AM IST
Govt clears Corbevax as Covid-19 booster dose for adults vaccinated with Covaxin, Covishield
This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.
Aug 10, 2022, 12:53 PM IST
CORBEVAX becomes first vaccine in India to get DCGI approval for COVID-19 booster dose
CORBEVAX has become the first vaccine in India to get DCGI approval for COVID-19 booster dose.
Jun 04, 2022, 17:28 PM IST
Monkeypox cases due to the side effect of AstraZeneca/Covishield vaccine? Answer is here
Monkeypox outbreak: Social media posts claiming the chimpanzee adenovirus vector used in AstraZeneca's Covid vaccine, causes Monkeypox have surfaces, PTI reported.
Jun 02, 2022, 17:55 PM IST
Sputnik booster dose approved in India, more than 6.5 lakh people eligible: Report
More than 6.5 lakh people who have received Sputnik COVID vaccine will soon be eligible to take the booster dose.
May 07, 2022, 14:28 PM IST
Several vials of Covid vaccine found in garbage dump in UP’s Kannauj, probe ordered
A probe has been ordered after several vials of Covishield vaccine were found in a garbage dump at a community health centre, reports PTI.
Apr 30, 2022, 17:02 PM IST
No more free of cost, Serum Institute finalises the price of Covishield Booster dose
Government have decided to allow Coronavirus booster shots to all adults from Sunday at private vaccination centres. The move was welcomed by Serum Institute of India CEO Adar Poonawalla today. He calls it a crucial and timely decision.
Apr 08, 2022, 17:58 PM IST
Fourth wave of Covid-19 to hit India? Here's what Serum Institute's CEO Adar Poonawalla has to say
Speaking to reporters on the sidelines of the ‘Alternate Fuel Conclave’, the SII CEO said the reason behind the low number of Covid-19 cases at the moment is that the country chose the right vaccine.
Apr 04, 2022, 21:35 PM IST
Covid-19: Amid fourth wave scare, expert body suggests reducing gap between Covishield doses
India's apex body on immunisation NTAGI has recommended administering the second dose of Covishield between eight and 16 weeks after the first dose.
Mar 21, 2022, 10:03 AM IST
Reduce Covishield dose gap to 8-16 weeks, recommends panel
The National Technical Advisory Group on Immunisation has recommended reducing the Covishield dose gap.
Mar 20, 2022, 18:15 PM IST
'Misleading': Centre on reports claiming 50 lakh unused Covishield doses may go waste by February end
The Health Ministry said that the Centre had proactively advised all state governments to review the availability of vaccines, right from the start of the vaccination drive against COVID-19, to ensure that the wastage of doses is reduced to a minimum.
Feb 03, 2022, 16:51 PM IST
Covishield, Covaxin likely to be capped at Rs 275 after regular market approval
The price is likely to be capped at Rs 275 per dose along with an additional service charge of Rs 150.
Jan 26, 2022, 16:13 PM IST
Covishield, Covaxin regular market approval recommended by govt panel
An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to Covid vaccines Covishield and Covaxin, which are currently only authorised for emergency use in the country, subject to certain conditions, official sources said.
Jan 19, 2022, 22:33 PM IST
Is mixing and matching Covishield, Covaxin safe? Study provides BIG update
A total of 330 volunteers, who were not vaccinated and had no history of the COVID-19 infection, were selected and screened for SARS-CoV-2 antibodies for the study.
Jan 04, 2022, 07:14 AM IST
Lancet study about Covishield 3 months efficacy misquoted, say experts
The Lancet study reportedly stated that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months.
Dec 23, 2021, 20:39 PM IST
Covishield booster dose: Subject Expert Committee to meet today to discuss approval
According to the Ministry of Health and Family Welfare, India has administered over 140 crore COVID-19 vaccine doses so far. More than 67 lakh (67,11,113) doses were administered till 7 pm on Thursday.
Dec 10, 2021, 06:32 AM IST
Third jab soon? Serum Institute asks DCGI to allow Covishield as booster dose
SII cited adequate stock of the vaccine in the country and a demand for a booster.
Dec 01, 2021, 21:20 PM IST
